PNEUMOCYSTIS PNEUMONIA

Clinical trials for PNEUMOCYSTIS PNEUMONIA explained in plain language.

Never miss a new study

Get alerted when new PNEUMOCYSTIS PNEUMONIA trials appear

Sign up with your email to follow new studies for PNEUMOCYSTIS PNEUMONIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

Trial challenges 3-Week steroid rule for deadly pneumonia

Disease control Not yet recruiting

This study aims to find the best length of steroid treatment for adults with weakened immune systems who have a severe lung infection called PCP. It will compare stopping steroids after 10 days (if the patient has recovered enough) to the standard 21-day course. The goal is to se…

Matched conditions: PNEUMOCYSTIS PNEUMONIA

Phase: PHASE4 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

PNEUMOCYSTIS PNEUMONIA

Get alerted when new PNEUMOCYSTIS PNEUMONIA trials appear

Trial challenges 3-Week steroid rule for deadly pneumonia